CHC's Options RCM Targets Same Revenue-Cycle Ground as R1 RCM
- Options RCM enters competition with R1 RCM and other large RCM vendors targeting hospital revenue‑cycle management. • CHC targets community hospitals, increasing competition where R1 RCM markets large‑scale, integrated health‑system solutions. • CHC’s launch pressures R1 RCM to offer bespoke services and rural‑market sensitivity alongside scale.
CHC’s Options RCM targets the same hospital revenue-cycle ground as R1 RCM
CHC Consulting launches Options RCM, a revenue cycle management offering designed to help rural and community hospitals shore up finances and preserve local care, placing it directly in the competitive landscape occupied by R1 RCM and other large RCM vendors. The service positions revenue-cycle work as strategic rather than administrative, stressing scalable engagements that range from targeted support for a single function to full outsourcing aimed at recovering missed revenue and lowering operating costs for hospitals with limited staffing and tight margins.
Options RCM pairs technology-driven analytics with experienced personnel and established processes to address common industry pain points — rising payer denials, complex prior authorization workflows, and constrained front‑line resources. CHC frames the service as tailored for smaller hospitals that may be underserved by national RCM providers, promoting local access preservation as a differentiator. That approach signals increased competition in the community hospital segment, where R1 RCM often markets large-scale, integrated solutions across health systems and where buyers are seeking both cost control and flexible deployment models.
The launch also underscores a broader industry shift toward modular, outcome-focused RCM offerings that combine vendor partnerships and performance transparency. By contracting with firms such as Currance and Optum, CHC blends third-party capabilities into a coordinated suite, reflecting a trend among RCM providers to assemble ecosystems rather than rely solely on proprietary platforms. For R1 RCM, CHC’s move highlights growing pressure to demonstrate bespoke service options and rural-market sensitivity alongside scale.
Operational scope and vendor ties
Options RCM covers the full revenue cycle — from front-end registration, verification and pre-authorization through pre-bill coding, billing and follow-up, cash posting, denial management and payment validation. CHC says hospitals can choose targeted modules or a full-service program, with vendor partners supplying supplemental technology and staffing where needed.
Performance metrics and tailored rollouts
CHC commits to delivering measurable results through dashboards and key performance indicators such as days in accounts receivable, denial rates, net collection rate and cash collections, and it tailors implementation timelines to hospital size, payer mix and staffing constraints. The initiative reflects mounting demand among community hospitals for tech-enabled RCM that balances measurable financial improvements with preservation of local care access.
Related Cashu News

HCA Healthcare Raises $3 Billion in Senior Unsecured Notes to Enhance Financial Flexibility
HCA Healthcare successfully completes a public offering of senior unsecured notes totaling US$3.00 billion. This significant move reflects the company’s commitment to bolstering financial flexibility…

IDEXX Laboratories Board Members Show Confidence Through Stock Option Exercises Amid Market Challenges
IDEXX Laboratories (Ticker: IDXX) demonstrates a strong commitment to its future growth as recent insider stock transactions reflect the confidence of its board members. On May 14, several board membe…

Centene Announces Leadership Changes to Strengthen Medicaid and Medicare Operations
Centene Corporation (Ticker: CNC) announces major leadership shifts aimed at boosting its Medicaid and Medicare sectors. These changes could positively impact the company’s strategic direction and ope…

Accuray Partners with University of Wisconsin to Advance Innovative Cancer Therapy Technologies
Accuray Incorporated (Ticker: ARAY) forges a significant decade-long partnership with the University of Wisconsin School of Medicine and Public Health to revolutionize personalized cancer care through…